Moreover, EMT phenotype in cancers has been associated with poor clinical outcome in multiple cancer types including NSCLC, yet the molecular mechanisms underlying the induction of EMT by TGF-β1 remain ill-defined especially for NSCLC [13]–[17]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.